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Subtelomeric 1p36 deletion gives rise to a common syndrome, with an incidence of 1: 5,000-1: 10,000 [Heilstedt et al., 2003] , characterized by intellectual disability, abnormal language and behavior, craniofacial features, seizures, ocular abnormalities, hearing loss, structural heart defects, and hypotonia [Shimada et al., 2015] . The size of 1p36 deletions is variable with a mean size of 5 Mb (calculated according to data from DECIPHER). Several studies have attempted to map the chromosomal regions in 1p36 associated with diverse phenotypes in patients with 1p36 deletion syndrome, focusing mainly on distal deletions [Shimada et al., 2015] . However, Kang et al. [2007] described 5 patients with an unusual phenotype carrying interstitial deletions extending from 1p36.23 to 1p36.11 and proposed a distinct proximal 1p36 deletion syndrome. Here, we report an unusual case with proximal 1p36 deletion syndrome presenting with Ebstein anomaly (EA) and discuss the role of haploinsufficiency in UBE4B and RERE as a likely additional causative defect for EA.
Case Report and Results
The index case is a 4-year-old boy, born to healthy nonconsanguineous parents, after 40 weeks of pregnancy in which polyhydramnios, maternal hypothyroidism, and vaginal leucorrhoea were recorded. At the time of birth, his father was 33 and his mother 37 years old. Both stated having an additional healthy child from a previous relationship. At birth, weight and height were 2,760 g (3rd percentile) and 51 cm (39th percentile), respectively. The patient presented with cyanosis, generalized hypotonia, and a swallowing disorder which required orogastric tube feeding, although an endoscopic study showed only a severe gastroesophageal reflux. An echocardiogram identified EA type B with moderate tricuspid valve insufficiency, a perimembranous ventricular septal defect, peripheral pulmonary stenosis, and a bicuspid aortic valve ( Fig. 1 D) . He presented with supraventricular tachycardia, which was easily controlled. Brain ultrasound was normal, tomography showed overriding cranial sutures and MRI revealed a diffuse subarachnoid space highlighting augmentation. Renal and abdominal echography proved normal. He was discharged from the hospital at 2 months. At the age of 1 year, he was hospitalized because of bacterial pneumonia and gastroenteritis; during his stay, 6 febrile seizures occurred with normal EEG. He received an ophthalmologic evaluation due to marked photophobia, finding keratoconus in the left eye and thin tortuous retinal vessels. Genetic studies revealed a negative MLPA result for 22q11 deletion and ruled out Mowat-Wilson syndrome by sequencing ZEB2 . Physical examination at age 4 years showed failure to thrive, a weight of 11.9 kg (0.4 percentile), height of 94 cm (0.7 percentile), and a head circumference of 47 cm (1.2 percentile). He also presented with distinctive features ( Fig. 1 A, B) , accompanied by hypotonia, pectus excavatum, marked linea alba which continues into the torso, hypochromic lines in the back that do not cross the midline, left cryptorchidism, short and broad phalanx of the fingers, broad palms, shortened halluces, and a sacral dimple ( Fig. 1 C) . A psychological interview and the Wechsler intelligence scale for toddlers (WPPSI-III) showed a marked delay in developmental milestones and a total intelligence quotient of 44 points (0.1 percentile).
To identify potential chromosomal abnormalities, cytogenetic microarray analysis was performed using the Affymetrix cytoscan 750K Human Genome CNV+SNP Genotype-phenotype correlation analysis of 1p36 deletions in patients with Ebstein anomaly (EA). A The patient shows an 11.95-Mb deletion in chromosome 1 identified by cytogenetic microarray analysis. B Reported 1p36 deletions in patients with EA (black lines), including patients with loss of only the EA-associated distal locus, loss of both the distal and proximal EA-associated loci, and loss of only the proximal EA-associated locus as well as our patient (red line). Below, the location of genes in the 1p36 region are shown which are expressed in heart tissue and are associated with heart development, heart physiology, and/or congenital heart defect (CHD).
array with 550,000 CNV non-polymorphic probes and 200,000 SNP probes with reference to genome version GRCh37 (hg19). The array identified an 11.95-Mb deletion in chromosome 1, with breakpoints at positions 4,629,407 and 16,586,999, affecting bands 1p36.32 to 1p36.13, and including 221 genes, with breakpoints located near distal and proximal nondeleted probes C-6MMTB and C-6WWZQ, respectively ( Fig. 2 A) . Two additional microduplications were identified, but not considered to be clinically relevant: the first one of 104 kbp in chromosome 17q21.31 (chr17: 44188450-44292742), involving the genes KIAA1267 and LOC644246 and the second one of 181 kbp in chromosome 6p21.2 (chr6: 36795665-36976418), involving the genes CPNE5 , PPIL1 , C6orf89 , PI16 , MTCH1 , and FGD2 . A 163-kbp microdeletion in chromosome 8p11.22 (chr8: 39226335-39388919), involving the genes ADAM5P and ADAM3A was also identified.
A search in Medline (https://www.ncbi.nlm.nih.gov/ pubmed/), ISCA (retrieved from https://decipher.sanger. ac.uk), and DECIPHER (https://decipher.sanger.ac.uk) [Firth et al., 2009] (with 1p36 CNV losses classified as likely pathogenic or definitely pathogenic) was performed to assemble a database of deletions (ranging from 1 to 22,000,000 bp) and phenotypes from EA patients with 1p36 deletions reported from 1999 to 2017 to identify overlapping regions associated with EA ( Fig. 2 B) . Reports without deletion coordinates or with low-resolution data or from nonpublic databases that could not be verified were excluded.
Discussion
The phenotype of the patient in this report is consistent with the previous description of proximal 1p36 deletion syndrome, including the presence of pre-and postnatal growth deficiency (mostly postnatal), feeding difficulties, arched eyebrows and the absence of characteristics associated with distal 1p36 deletions such as hearing loss and straight eyebrows [Kang et al., 2007] .
In the literature and database search, EA was found in only 10/302 patients with 1p36 deletions. Our patient showed loss of the proximal region of 1p36, but did not show loss of either the critical region (CR) in reported cases with EA or PRDM16 ( Fig. 2 ) , the gene proposed by Shimada et al. [2015] in the distal region to be associated with EA. PRDM16 has been found in the region of minimal genomic overlap in individuals with 1p36 deletion syndrome, left ventricular noncompaction, and dilated cardiomyopathy, which was further assessed by Arndt et al. [2013] in 2 cohorts of nonsyndromic patients with this type of cardiomyopathy, independently, detecting 3 mutations including a truncation mutant, a frameshift null mutation, and a single missense mutant. Hence, this is the first reported case of a patient with a proximal deletion presenting with EA ( Fig. 2 ) . The distal breakpoint in the identified deletion is more than 1 Mb away from the region shared by all other reported EA cases with 1p36 deletions, making it unlikely that this deletion affects a regulatory region for genes contained in the previously reported CR. This finding suggests that PRDM16 loss is not required for the development of EA in 1p36 deletion syndrome, and that loss of an additional proximal locus in 1p36 is also likely associated with EA.
Our data suggest that delimiting 2 separate CRs in 1p36 is required to explain the cardiac phenotype identified in EA patients with 1p36 deletions. Therefore, it is likely that there are 2 independent loci where haploinsufficiency can contribute to the development of EA, as has been proposed by Jordan et al. [2015] and Zaveri et al. [2014] for different forms of congenital heart defects (CHD). The distal CR is delimited by the patient described by Digilio et al. [2011] and contains both PRDM16 and SKI gene, the latter previously associated with CHD in animal models [Doyle et al., 2013] and human genetic studies [Zhu et al., 2013; Cunnington et al., 2014; Shimada et al., 2015; Zeglinski et al., 2016; Wu et al., 2017] ( Fig. 2 ) . Patients with heterozygous missense mutations and in-frame deletions in SKI show a multisystemic connective tissue disorder, called ShprintzenGoldberg syndrome, characterized by a marfanoid habitus, craniosynostosis, severe skeletal muscle hypotonia, intellectual disability, and cardiovascular abnormalities such as mitral valve prolapse and aortic dilation [Carmignac et al., 2012; Schepers et al., 2015] . The proximal CR is delimited by the deletion reported here. It is important to note that the proximal CR does not contain PRDM16 and suggests that this gene is not necessary for the development of EA in patients with 1p36 deletions ( Fig. 2 ) .
The deletion of this case contains approximately 221 genes, including genes which are highly expressed in heart tissue and have been implicated in heart physiology or cardiac development in human, animal, or cell culture models [Jordan et al., 2015] , specifically KCNAB2 , RNF207 , UTS2 , RERE , UBE4B , CASZ1 , MTOR , NPPA , NPPB , PLEKHM2 , FBLIM1 , ZBTB17 , HSPB7 , ARH-GEF19 , NBPF1 , PDPN , and SPEN. However, only 7 of these genes have been linked to congenital heart disease in humans or mouse models and are more likely to be associated with cardiac phenotypes in 1p36 deletion patients, namely RERE , UBE4B , CAZ1 , MTOR , PDPN , PLEKHM2 , and SPEN ( Fig. 2 ) . With the exception of PDPN , PLEKHM2 , and SPEN , hemizygosity has been reported for all of these genes in patients with EA, including 2 ( UBE4B and RERE ) which have been implicated in the development of CHD through the regulation of myocardial development [Kaneko-Oshikawa et al., 2005; Kim et al., 2013] and are likely responsible for EA in these patients ( Fig. 2 ) .
Ube4b is involved in mouse cardiac development, and expressed in the heart muscle during embryogenesis and adulthood. Ube4b -knockout mice show enlarged hearts associated with pericardial effusion, indicative of congestive heart failure and reduced trabeculation as well as an undeveloped and compact myocardial layer with increased cardiomyocyte apoptosis during embryogenesis. Deletion of UBE4B leads to a misregulation of genes such as GATA6 which have been implicated in the regulation of myocardial differentiation during cardiogenesis [Kaneko-Oshikawa et al., 2005] . No human phenotype of UBE4B haploinsufficiency has been described.
On the other hand, mice carrying null and hypomorphic alleles of Rere had several abnormalities including CHD. Rere -null mice die of cardiac failure between 9.5 and 11 weeks of embryogenesis, while heterozygous mice carrying a hypomorphic allele have a high frequency of cardiovascular malformations [Kim et al., 2013] . Fregeau et al. [2016] reported 10 cases of RERE de novo mutations, in which patients presented with neurodevelopmental disorders, hypotonia, structural eye defects, and genitourinary defects; 40% had CHD, most commonly ventricular septal defect.
Alternatively, a single patient with tetralogy of Fallot and bicommissural aortic valve led Zaveri et al. [2014] to propose an additional third region associated with CHD, from 12,726,755 to 20,540,759 bp, affecting the genes PDPN and SPEN (previously known as MINT ) , which have been shown to be associated with CHD in mouse models [Kuroda et al., 2003; Mahtab et al., 2009] . Although the patient reported here presents a different form of CHD, his deletion shows significant overlap with this proposed third region, so we cannot rule out the involvement of these genes in this patient's phenotype. Furthermore, CHD associated with 1p36 deletions may be caused by positional effects brought on by changes in the chromosomal architecture, as suggested by Redon et al. [2005] . According to this hypothesis, haploinsufficiency of specific genes contained within the observed deletions may not be causative for the observed phenotypes. Instead, the altered chromosomal environment may result in changes in gene expression of targets located distant to the deletion.
In conclusion, this report represents the first case of a patient with EA carrying a proximal 1p36 deletion, which does not show overlap with the previous CRs reported in other EA patients, suggesting the presence of an additional proximal locus associated with EA. Further studies of the genes contained in these regions in patients with nonsyndromic forms of EA and functional studies are required to determine their role in the pathogenesis of this cardiac defect. Likewise, identification of additional patients with EA carrying proximal 1p36 deletions can further define the proximal region associated with the disease.
